All the Latest on Viral Clearance from the 2017 Viral Clearance Symposium
The September/October edition of the PDA Journal of Pharmaceutical Science and Technology features summaries of presentations at the 2017 Viral Clearance Symposium. Topics covered include virus barrier filters, virus filtration and more!
Editorial
- Richard Levy, “Special Viral Clearance Issue and St Gallen PDA
Collaboration Paper“
- Franz Nothelfer, Stefan Hepbildikler, “Proceedings of the 2017 Viral
Clearance Symposium – Introduction“
Review
- Glen Bolton, Dayue Chen, “Upstream Mitigation Part 1: Cell Bank and
Bulk Harvest Testing“
- Dayue Chen, Glen Bolton, “Session 1.1 Upstream Mitigation Part 2:
Virus Barrier Filter and HTST“
- Thomas Kreil, David Roush, “Proceedings of 2017 Viral Clearance
Symposium Session 2.1: DSP Unit Operations – Virus Filtration/
Inactivation“
- Thomas Kreil, David Roush, “Proceedings of 2017 Viral Clearance Symposium
Session 2.2: DDSP Unit Operations – Purification Unit Operations“
- Johannes Bluemel, Junfen Ma, “Proceedings of 2017 Viral Clearance
Symposium Session 3: Resin Life Time“
- Astrid Schwantes, Qi Chen, Rachel Specht, “Proceedings of 2017 Viral
Clearance Symposium Session 4: Submission Strategies“
- Junfen Ma, Thomas R. Kreill, “Proceedings of 2017 Viral Clearance
Symposium Session 5: Facility Risk Mitigation“
- Sarah Johnson, David Roush, “Proceedings of 2017 Viral Clearance
Symposium Session 6: Ensuring Viral Safety in Continuous
Processing“
Editorial
- Stefan Hepbildikler, Sarah Johnson, Johannes Bluemel, “Viral
Clearance Symposium 2017 Conclusion“
Research
- Paul Buess, et al., “The Impact of Quality Culture on Operational
Performance – An Empirical Study from the Pharmaceutical Industry“